The largest database of trusted experimental protocols

11 protocols using anti cd71

1

HPV16 Peptide-Mediated Immune Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
On D0, PBMCs from 6 healthy women donors (from 25 to 35 years old) were incubated at the density of 200,000 cells/well in 96-well plates in Roswell Park Memorial Institute (RPMI) 1640 medium (Panbiotech, P04-17500), added with 2% human decomplemented serum, 1 mM non-essential amino acids, 1 mM pyruvate, 2 mM L-glutamine, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, in the presence of HPV16(L1) peptide mix at the final dilution of 1/450 v/v. On D2, either the Veh., MIM-1; -2; -3; -4 or -5 were added to the medium and incubated for the next 72 h at the final sucrose–lactose concentration of 11 mM. Controls with either HPV16(L1) or IL-2 (20 ng/mL) were also run in parallel. On D5, the cells were harvested, saturated with FcBlock solution (BD, 564220), immune-stained with fluorescent anti-CD3, anti-CD4, anti-CD8, anti-CD71, anti-CD95, anti-CD28 and anti-HLA-DR antibodies (all purchased from BioLegend), fixed, and analyzed by flow cytometry. The discrimination of the cell sub-populations is as follows: CD4+: CD3high; CD4high; CD8low; SSClow, CD8+: CD3high, CD4low, CD8high, SSClow, CD4/CD8: CD3high; CD4low; CD8low; SSClow. The supernatants (SNs) were retrieved and the cytokine levels of IFN-γ, IL-6, and interferon- γ inducible protein (IP-10) were assessed by enzyme-linked immunosorbent assay (ELISA).
+ Open protocol
+ Expand
2

Monoclonal Antibodies for Cell Surface Marker Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat monoclonal anti‐SSEA3 (Clone MC‐631) along with the following mouse monoclonal antibodies were used: anti‐SSEA3, anti‐SSEA4 (Clone MC‐813–70), anti‐CD34 (Clone V MA27), anti‐CD41 (Integrin GPIIb, Clone IV P38), anti‐CD235ab (Glycophorin A/B, Clone VII 70299), anti‐CD235a (Glycophorin A, Clone VII 70312), anti‐CD71 (transferrin receptor, Clone A015) (Biolegend, San Diego, CA); anti‐CD238 (Kell, Clone BRIC 203), anti‐CD234 (Duffy, Clone 2C3) (BD Biosciences, San Jose, CA); anti‐RhAG (Clone LA1818) (kindly provided by Prof Ellen van der Schoot, Sanquin, Amsterdam, Netherlands); anti‐RhD/CE (Clone BRIC69, Fisher Scientific); anti‐U (Glycophorin B, Human plasma, Versiti‐Wisconsin); anti‐CD233 (BAND3, Clone BRIC6, American Research Products, Palos Verdes Estates, CA); anti‐CD173 (H antigen, Clone BRIC 231, MyBioSource, San Diego, CA). Secondary antibodies used were as follows: monoclonal APC‐conjugated Rat anti‐mouse IgG1 (Clone RMG1‐1, Biolegend) and polyclonal APC‐conjugated goat anti‐human IgG (Fab) (RRID: AB_2337691, Jackson Laboratories, Bar Harbor, ME).
+ Open protocol
+ Expand
3

Murine Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
A single cell suspension from thymi and spleens of 4–6 week-old mice was obtained using a Dounce homogenizer. Cells were first preincubated for 10 min on ice with Fc receptor-blocking anti-CD16/32 (clone 93) antibody in PBS-1% biotin-free BSA solution and then stained for 20 min with specific primary antibodies. Biotinylated primary antibodies were revealed with streptavidin conjugated fluorescent dyes (SAv-PE/Cy7, SAv-APC, SAv-APC/Cy7). Labeled cells were analyzed on BD FACSCantoII (BD Biosciences) or CytoFLEX (Beckman Coulter) flow cytometers and data analysis was performed using FlowJo software (FlowJo, LLC). Clones of monoclonal antibodies were: anti-CCR6 (29–2L17), anti-CD3ε (145–2C11), anti-CD4 (GK1.5), anti-CD5 (53–7.3), anti-CD8 (53–6.7), anti-CD11c (N418), CD24 (M1/69), anti-CD25 (PC61), anti-CD27 (LG.3A10), anti-CD28 (E18), anti-CD44 (IM7), anti-CD45.1 (A20), anti-CD45.2 (104), anti-CD71 (RI7217), anti-CD73 (TY/11.8), anti-CD117 (c-Kit, 2B8) anti-B220 (RA3–6B2), anti-CD11b (Mac1, M1/70), anti-γδT-cell (GL3), hamster IgG-PE/Cy7 (HTK888), anti-Ly6G/Ly6C (GR1, RB6–8C5), anti-Nk1.1 (PK136), anti-Tcrβ (H57–597), anti-Tcrβ(Vα2) (B20.1), Ter-119 (all from Biolegend). Splenocytes were analyzed as previously described (18 (link)).
+ Open protocol
+ Expand
4

Quantifying Immune Cell Phenotypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
We performed cell surface staining with fluorescence-conjugated antibodies in 2% FBS–PBS. We obtained fluorochrome-conjugated anti-CD11b, anti-F4/80, anti-CD71, and anti-CD98 from Biolegend. We identified cell death using a violet Live/Dead kit (Invitrogen). We performed intracellular staining for Alexa Fluor 647-conjugated p-Akt (Ser473) and p-4EBP1 (Thr37/46) (Cell Signaling Technology) using BD Biosciences Cytofix/Cytoperm and Perm/Wash solutions. We collected data using a BD FACSAria II and analyzed them with FlowJo (Treestar).
+ Open protocol
+ Expand
5

Isolation of Murine Erythroid Progenitor and T Cell Populations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes were collected by mechanical disruption. Cell suspensions were passed through 70-μm cell strainers and then washed and resuspended in staining buffer. For the isolation of spleen CD45+Ter119+CD71+cells(CD45+EPC), cells were stained with anti-CD45 monoclonal antibody (mAb),anti-Ter119 (mAb), and anti-CD71 (both from Biolegend). Then, CD45+EPC were sorted using the BD FACSAsia II Special Order System. For spleen CD8+ T cell isolation, CD8+T lymphocytes were isolated from spleens of wild type mice using T-cell enrichment columns (Stem Cell). For all sorted samples, a purity of greater than 95% was achieved.
+ Open protocol
+ Expand
6

Characterization of Neural Derived Progenitor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
nDPSC were harvested by trypsin/EDTA treatment for 5 min at 37 °C. After inactivation of trypsin and centrifugation (5 min at 300 g), 100 µl of the cell suspension (105 cells) was incubated for 30 min at room temperature in the dark with the following fluorochrome-conjugated antibodies: anti-CD10 (eBiosciences; Clone: CB-CALLA), anti-CD13 (eBiosciences; Clone: WM-15), anti-CD29 (Chemicon, Clone: TDM29), anti-CD34 (Biolegend; Clone: 4H11), anti-CD44 (Caltag; Clone: MEM-85), anti-CD45 (Caltag; Clone: HI30), anti-CD71 (Biolegend; Clone: MEM-75), anti-CD73 (BD Pharming; Clone: AD2), anti-CD90 (Chemicon; Clone: F15-42-1), anti-CD105 (Caltag; Clone: SN6), anti-CD146 (Millipore; Clone: P1H12), anti-CD166 (Beckman; Clone: 3A6), anti-CD222 (eBiosciences; Clone: MEM-238), anti-CD271 (Biolegend; Clone: ME20.4), anti-CXCR4 (Caltag; Clone: 12G5), anti-INF-beta (INFsource; Clone: MMHB-3) and anti-HLA-DR (Caltag; Clone: Tu36). After washing with PBS, at least 10,000 events were acquired using a Beckman Coulter FC500 flow cytometer. Instrument settings and gating strategies were established using isotype controls, and data were analysed using Kaluza software (Beckman Coulter). All experiments were carried out in duplicates.
+ Open protocol
+ Expand
7

Flow Cytometry Analysis of PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh PBMCs were used for each flow cytometry analysis. Cells were suspended in phosphate-buffered saline (PBS) and incubated with antibody cocktails in the dark at room temperature for 15 min. After incubation, the cells were washed and resuspended in PBS and then analyzed. Data were acquired using an EC-800 (Sony Biotechnology Inc., Champaign, IL, USA) and analyzed with the Kaluza software program (Beckman Coulter, Brea, CA, USA). Forward scatter and side scatter gates were set to capture the cell population of interest, including monocytes and lymphocytes. We excluded the debris fractions to eliminate aberrant binding events due to dead cells as other groups did34 (link),51 (link). The following antibodies were used: anti-GPA (17-9987-42; eBiosciences, San Diego, CA, USA), anti-CD36 (IM0766U; Beckman Coulter), anti-CD45 (2120080; Sony Biotechnology Inc.), and anti-CD71 (334106; Biolegend, San Diego, CA, USA).
+ Open protocol
+ Expand
8

Macrophage Polarization and JUNV Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
MEM, RPMI, and FBS were purchased from Invitrogen (Buenos Aires, Argentina). rM-CSF was acquired from R&D Systems (Minneapolis, MN, USA). Anti JUNV antibodies were obtained from BEI resources, USA. Anti CD71, CD14, CD86, CD80, HLA-DR, CD11b, CD11c, CD64, CD163, CD206 were obtained from BioLegend (San Diego, CA, USA). Anti-human APC-MERTK (mouse IgG1), Biotin-AXL (goat IgG) and isotype controls were obtained from R&D Systems (Minneapolis, MN, USA). Anti-TYRO3 (rabbit IgG) was obtained from Novus Biological (Littleton, CO, USA). DAPI was purchased from Invitrogen (Buenos Aires, Argentina). ELISA kits (Ready-SET-Go kits) for TNF-α, IL-1β, IL-6, IL-10, and IL-12p70 were obtained from eBioscience, Fisher scientific, Pittsburgh, PA, USA. Cytofix/Cytoperm kit was purchased from BD Bioscience (San Diego, CA, USA).
+ Open protocol
+ Expand
9

Murine CD4+ T Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vitro experiments, primary murine naïve CD4 T cells were isolated from the spleens and LNs of female control C57BL/6 (JAX, #000664) or age-matched lupus-prone SLE1.2.3 mice (JAX, #007228) using the CD4+CD62L+ T cell isolation kit according to the manufacturer’s instructions (Miltenyi Biotec). CD62L-positive selection was routinely ~98% in purity, as determined by flow cytometry. Cell cultures were activated in the presence of either anti-CD71 (BioLegend, 113821) or isotype control (IgG2a; BioLegend, 400543) at 2 μg/ml, and downstream experiments were performed between days 3 and 6 after activation. For in vivo anti-CD71 experiments, female control or age-matched SLE1.2.3 mice were treated with 200 μg of CD71-blocking antibody (clone R17 217.1.3/TIB-219) or an isotype control antibody starting at 4 to 5 months of age (Bio X Cell). Treatment was administered twice a week via intraperitoneal injection for 4 weeks.
+ Open protocol
+ Expand
10

Cell Proliferation Analysis by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
To measure cell proliferation, cells were stained with a CellTrace Violet Cell Proliferation kit (Thermo Scientific) prior to culturing. Flow cytometry staining was undertaken in 96-well round-bottom plates with a minimum of 200,000 cells per well. To distinguish live cells, the cells were stained with a LIVE/DEAD Fixable Aqua Dead Cell Stain kit (Thermo Scientific). For surface staining, the cells were incubated in Facs buffer (2.5% FBS and 0.05% sodium azide in PBS) with labeled antibodies, all Thermo Scientific unless otherwise indicated: anti-CD8β, anti-CD25, anti-CD69 (BioLegend), anti-CD71 (BioLegend) and anti-CD98. Intranuclear staining was done using the eBioScience Foxp3/Transcription Factor Staining kit (Thermo Scientific) and anti-Irf4, anti-T-bet, and anti-c-Myc (Cell Signaling) antibodies. Flow cytometry was performed on a MacsQuant Analyzer 10. Flow cytometry data were analyzed using FlowJo 10 software. Flow cytometry data were generated within the Flow Cytometry and Cell Sorting Facility in Ashworth, King's Buildings at the University of Edinburgh.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!